Literature DB >> 23123737

Involvement of the ANGPTs/Tie-2 system in ovarian hyperstimulation syndrome (OHSS).

Leopoldina Scotti1, Dalhia Abramovich, Natalia Pascuali, Ignacio de Zúñiga, Alejandro Oubiña, Laura Kopcow, Soledad Lange, Gareth Owen, Marta Tesone, Fernanda Parborell.   

Abstract

Ovarian hyperstimulation syndrome (OHSS) is a disorder associated with ovarian stimulation. OHSS features are ovarian enlargement with fluid shifting to the third space. Disturbances in the vasculature are considered the main changes that lead to OHSS. Our aim was to analyze the levels of angiopoietins 1 and 2 (ANGPT1 and 2) and their soluble and membrane receptors (s/mTie-2) in follicular fluid (FF) and in granulosa-lutein cells culture (GLCs) from women at risk of developing OHSS. We also evaluated the effect of ANGPT1 on endothelial cell migration. In ovaries from an OHSS rat model, we analyzed the protein concentration of ANGPTs, their mTie-2 receptor, and platelet-derived growth factor PDGF-B, -D and PDGFR-β. ANGPT1 levels were increased in both FF and GLCs from women at risk of OHSS. Incubation of these FF with an ANGPT1 neutralizing antibody decreased endothelial cell migration. In the ovaries of OHSS rat model, mTie-2 protein levels increased and PDGF-B and -D decreased. In summary, these results suggest that ANGPT1 could be another mediator in the development of OHSS.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23123737     DOI: 10.1016/j.mce.2012.10.022

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  3 in total

1.  THE ROLE OF HIGH FOLLICULAR LEVELS OF ANGIOTENSIN II AND VASCULAR ENDOTHELIAL GROWTH FACTOR IN ANTICIPATING THE DEVELOPMENT OF SEVERE OVARIAN HYPERSTIMULATION SYNDROME IN PATIENTS WITH PROPHYLACTIC CABERGOLINE THERAPY UNDERGOING AN IN VITRO FERTILIZATION PROCEDURE.

Authors:  M Surcel; M Surcel; C Zlatescu-Marton; R Micu; G I Nemeti; D D Axente; C Mirza; I Neamtiu
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Jan-Mar       Impact factor: 0.877

2.  Metformin decreases the incidence of ovarian hyperstimulation syndrome: an experimental study.

Authors:  Evelin M Elia; Ramiro Quintana; Carlos Carrere; María V Bazzano; Gastón Rey-Valzacchi; Dante A Paz; María C Pustovrh
Journal:  J Ovarian Res       Date:  2013-09-08       Impact factor: 4.234

3.  SARS-CoV-2 infection negatively affects ovarian function in ART patients.

Authors:  Yamila Herrero; Natalia Pascuali; Candela Velázquez; Gonzalo Oubiña; Vanesa Hauk; Ignacio de Zúñiga; Mariana Gómez Peña; Gustavo Martínez; Mariano Lavolpe; Florencia Veiga; Fernando Neuspiller; Dalhia Abramovich; Leopoldina Scotti; Fernanda Parborell
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-10-27       Impact factor: 5.187

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.